MIM
GILD icon

Macroview Investment Management’s Gilead Sciences GILD Stock Holding History

Macroview Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10
Closed -$750 – 715
2023
Q3 		$750 Buy
+10
New +$769 ﹤0.01% 690
2023
Q1 		– Sell
-135
Closed -$11.6K – 477
2022
Q4 		$11.6K Buy
+135
New +$10.7K 0.02% 188
2020
Q2 		– Sell
-50
Closed -$4K – 344
2020
Q1 		$4K Buy
+50
New +$3.46K 0.01% 154
2014
Q3 		– Sell
-45
Closed -$4K – 242
2014
Q2 		$4K Hold
45
– – 0.01% 111
2014
Q1 		$3K Buy
+45
New +$3.53K ﹤0.01% 201

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macroview Investment Management's GILD Position: Q4 2023 in Review

Macroview Investment Management sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 10 shares — an estimated $750 sold.

Macroview Investment Management first reported a position in GILD in Q1 2014 and held it in 5 quarters. The position peaked at $11.6K in Q4 2022. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Macroview Investment Management reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • Macroview Investment Management sold 10 Gilead Sciences shares in Q4 2023, an estimated $750.
  • Macroview Investment Management first reported a position in Gilead Sciences in Q1 2014 and held it in 5 quarters.
  • Macroview Investment Management's Gilead Sciences position peaked at $11.6K in Q4 2022.
  • 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Macroview Investment Management's 13F filing for Q4 2023, filed 30 Jan 2024.